GAINESVILLE, Fla.–(BUSINESS WIRE)–AGTC receives significant grant funding from the Foundation Fighting Blindness to develop treatment for genetic eye disease, XLRS, causing blindness in young boys.
Author: Business Wire
Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 1/2 Clinical Trial for OPA-6566 in Patients with Open-angle Glaucoma or Ocular Hypertension
SEATTLE & TOKYO–(BUSINESS WIRE)–Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 1/2 clinical trial for…
EyeMed Vision Care Expands Member Wellness Focus with Diabetic Eye Care Benefit
MASON, Ohio–(BUSINESS WIRE)–EyeMed Vision Care introduces a new Diabetic Eye Care benefit that provides follow-up care and supplementary diagnostic testing for patients with diabetes, a leading cause of adult blindness. Full Story →
Neurotech’s NT-501 Implant Slows Vision Loss in Patients with Geographic Atrophy Associated with Dry AMD as Reported in PNAS
LINCOLN, R.I.–(BUSINESS WIRE)–Neurotech announced that it was reported in PNAS that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy associated with dry AMD in a Phase 2 study. Full Story →
Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that one of two Phase III studies evaluating monthly Lucentis® (ranibizumab injection) in patients with diabetic m…
Alcon Posts Solid Fourth Quarter Financial Results
HUENENBERG, Switzerland–(BUSINESS WIRE)–Alcon, Inc. (NYSE:ACL) reported that global sales rose 5.7 percent to $1.81 billion for the fourth quarter of 2010. Revenue from acquisitions added 100 basis points to sales growth in the quarter, while foreign…
Research and Markets: Ophthalmic Devices Market Outlook in Japan to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/885688/ophthalmic_devices) has announced the addition of GlobalData’s new report “Ophthalmic Devices Market Outlook in Japan to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Ophthalmic Devices Market Outlook in Japan…
Research and Markets: Ophthalmic Devices Market Outlook in the United States (US) to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/e86f8c/ophthalmic_devices) has announced the addition of GlobalData ‘s new report “Ophthalmic Devices Market Outlook in the United States (US) to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Full Story…
Research and Markets: Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/fb0df2/ophthalmic_devices) has announced the addition of GlobalData’s new report “Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Ophthalmic Devices Market Outlook in India…
Company Profile for Acucela Inc.
–(BUSINESS WIRE)–Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwid…
Research and Markets: Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4f2453/cataract_surgery) has announced the addition of GlobalData’s new report “Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market For…
Alcon and Novartis Agree to Merger Terms
HUENENBERG, Switzerland–(BUSINESS WIRE)–Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not…
InSite Vision Names Timothy Ruane Chief Executive Officer
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has appointed Timothy Ruane as Chief Executive Officer (CEO) and elected Mr. Ruane to its Board of Directors, effective Decem…
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
Research and Markets: Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. The report provides key data, information and analysis on the global premium IOLs market. Full Story…
Tallis PR: Ophthalmos Collects Platinum Award for Lens-Free Ophthalmoscope
LONDON–(BUSINESS WIRE)–New screening device wins at Nursing Times Product Awards Optyse™, the lens-free ophthalmoscope has been recognised with a Platinum Award in the Patient Observation category at the inaugural Nursing Times Product Awards. The …
OptiMedica’s Catalys™ Precision Laser System Study Published in Science Translational Medicine Shows Marked Advancement in Cataract Surgery
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica’s Catalys Precision Laser System study featured in the peer-reviewed journal Science Translational Medicine. Results show dramatic improvement in the precision of cataract surgery. Full Story →
Iris Pharma, Winner of the High Performance Prize in the Growth Category
NICE, France–(BUSINESS WIRE)–IRIS PHARMA, WINNER OF THE HIGH PERFORMANCE PRIZE IN THE GROWTH CATEGORY.
pSivida Corp. to Present at the Maxim Group Growth Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida to present at Maxim Group Growth Conference
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2010
WORCESTER, Mass.–(BUSINESS WIRE)–RXi Pharmaceuticals Corporation (Nasdaq: RXII) today reported its financial results for the third quarter ended September 30, 2010. RXi Pharmaceuticals is a recognized leader in RNAi-based therapeutic discovery and development with a comprehensive therapeutic platform that includes both…